Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Developing a blood test for Alzheimer's disease using advanced genomic expression technology.
Einstein
Richard
R
ExonHit Therapeutics, Inc, Gaithersburg, MD, USA. reinstein@exonhit.com
D000368:Aged; D000544:Alzheimer Disease / Q000097:blood / Q000175:diagnosis* / Q000235:genetics*; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D015331:Cohort Studies; D020869:Gene Expression Profiling / Q000379:methods* / Q000639:trends; D023281:Genomics / Q000379:methods / Q000639:trends; D006403:Hematologic Tests / Q000592:standards* / Q000639:trends; D006801:Humans; D008967:Molecular Biology / Q000379:methods / Q000639:trends; D009313:National Health Programs; D011446:Prospective Studies; D012313:RNA / Q000032:analysis* / Q000235:genetics; D014481:United States
D015415:Biomarkers; D012313:RNA